Equity Capital Markets

Company · CIK 1821323

Sigilon Therapeutics, Inc.

CIK1821323 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
Listedno ticker on SEC record today
First annual or quarterly report2021-03-18

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-264296
ShelfEffective
 2022-04-142023-08-153
333-250070
IPOFinal prospectus
 2020-11-132020-12-074

Filings

8
FiledFilingRegistrationAccession
2023-08-15EFFECTDeclared effective 333-2642969999999995-23-002390
2022-04-22EFFECTDeclared effective 333-2642969999999995-22-001068
2022-04-14S-3Shelf registered 333-2642960001558370-22-005474
2020-12-07424B4Final prospectus 333-2500700001047469-20-005656
2020-12-03EFFECTDeclared effective 333-2500709999999995-20-003393
2020-11-30S-1/AAmendment 333-2500700001047469-20-005603
2020-11-13S-1Registration filed 333-2500700001047469-20-005479
2020-08-21DRSDraft made public 377-034430001104659-20-097660

All filings of this company · CSV